From alt.support.mult-sclerosis Thu Mar 20 16:25:59 1997
From: MARK GUMKOWSKI <gumkowski@worldnet.att.net>
Date: Mon, 10 Mar 1997 21:41:04 -0500
Newsgroups: alt.support.mult-sclerosis
Subject: Re: Cladribine Trial Results in NJ
Status: O
X-Status: 

Jackie Ferguson wrote:
> 
> horowitz@admin.njit.edu wrote:
> >
> > I have news about the cladribine trial results.  Apparently, they were
> > inconclusive...
> 
> Then LaVonne Nurphy wrote: ... Protocol was developed at Scripps
> Clinic.  They have not finished their testing there...   None of the
> drugs for MS is effective for everyone.
> 
> I heard from 2 of our MS compatriots, from B.C., Canada ... that their
> results showed that the experimental group and controls were the same.
> 
> I spoke with one of the big MS guru's (one who orders clad.).  He was
> quite critical of the study design, esp. that they stopped after only a
> year; they didn't adequately distinguish between those with with primary
> cpms and those with secondary progressive MS.
> 
> I took a series of Cladribine IV's last year, from August 1995 to
> February 1996. I think it helped me.
> 
> I'm profoundly disappointed that the study period wasn't longer or that
> it wasn't better controlled.
> 
> Jackie Ferguson, RN, MS (squared)

Hi 
 I just recieved my results today from the Cladribine study @ Yale
2-28-97.
 I was in the high dose group but like you said 'very disappointing
results' was the consensus. My EDSS graphed over the study period was
flat with no change at all (3.5 after 12 visits). I make a visit to Yale
on 3-11 to see where I go from here. Bee venom therapy? Avonex? Continue
for years on non-effective Cladribine? I would like to hear about the
information you have gleaned from others regarding the study. By The way
I'm very new to this newsgroup stuff. Please Respond. Take-Care
 Mark Gumkowski
gumkowski@worldnet.att.net

From alt.support.mult-sclerosis Sat Mar 22 12:13:10 1997
From: LaVonne Murphy <mscansd2@worldnet.att.net>
Date: Wed, 19 Mar 1997 23:47:16 -0800
Newsgroups: alt.support.mult-sclerosis
Subject: 4AP CAUTION!!!
Status: O
X-Status: 

Hi Gang

Just learned something interesting about 4AP today.  Please rethink using 
this drug!

The study has been stopped again.  They are unable to keep the medication 
stable once it is formulated.  It is important that blood levels be 
checked OFTEN because there is a fine line of therapeutic dosage.  IF THE 
MED BECOMES UNSTABLE AND THE DOSAGE EXCEEDS THAT LINE YOU *WILL* HAVE 
SEIZURES!!!!  (Yep, if you are on this drug or considering it, I'm 
yelling at you.)  MS clinics have been monitoring what happens with folks 
that are using this drug and they (across the country) are reporting high 
rates of folks coming into emergency rooms with seizures.

It does not seem to matter where you get the drug, it can not be 
adequately stabelized.  Folks who order in quantities for more than a 
couple of weeks are having more problems than others.  A lot of the folks 
seen report getting the drug out of Texas somewhere.

PLEASE CONSIDER, is it worth it???
               L

From alt.support.mult-sclerosis Mon Mar 24 10:57:36 1997
From: anand ivatury <coldspot@pipeline.com>
Date: Fri, 21 Mar 1997 06:16:41 -0800
Newsgroups: alt.support.mult-sclerosis
Subject: Re: 4AP CAUTION!!!
Status: O
X-Status: 

Kathy G. wrote:
> 
> Yvonne,
> Please give me more specifics on the information you got on 4AP.  Where did
> you read this?
> Kathy G.
I have been on 4-AP for 9months now, 5MG 3 times a day, and have had
wonderful results, i have gained weight and more importantly, i can walk
again, most off the time WITHOUT a cane. Not only that, because of the
excellent results I have gotten, My insurance company is paying for the
drug. I hope it works for every one else as well as it has worked for
me.
good luck
anand  ( coldspot@pipeline.com )

From alt.support.mult-sclerosis Mon Mar 24 10:58:10 1997
From: KYXE19A@prodigy.com (Pat Logan)
Date: 23 Mar 1997 04:44:58 GMT
Newsgroups: alt.support.mult-sclerosis
Subject: Re: 4AP CAUTION!!!
Status: O
X-Status: 

I don't know how to reach the originator of this thread but it is only 
fair to say 4-AP has helped many of us with MS when nothing else has.  I 
feel it is unkind to downplay something that pwms are getting help from.  
For example, betaseron may have made you deathly ill while it has helped 
someone else, or IV Sol, or IVIg, etc.  I don't think we are here to 
proselatize (sp?) about the strengths/weaknesses of drugs for pwms...many 
of the drug companies pay millions to do that.  What we do best is share 
our experiences.  4-AP gave me back a full point on the EDSS and 
continues to abolish fatique and allow much better stamina and use of 
upper body....so I can write this note....3 years of use later.  And I'm 
not brain dead. 
                                                                          
                       Pat in Seattle 


From alt.support.mult-sclerosis Tue Mar 25 16:04:17 1997
From: gsh8@gholt.top.monad.net
Date: Sun, 23 Mar 97 07:10:52 PDT
Newsgroups: alt.support.mult-sclerosis
Subject: Re: 4AP CAUTION!!!
Status: O
X-Status: 


A man that my husband works with swears by 4-AP and states that it gave him 

back his life!!!!  He has the energy, after working all day, to now play with 

his kids.  Who knows what the long term effects of any of our remedies will be, 

but if it gives you what you need for now, that is what counts.  I have learned 

that everything in life is a 'trade-off':):):)  You just need to weigh 

everything and become educated and informed!  I personally would not take 

Betaseron, but I certainly do not fault those that choose to and am thrilled 

when I hear that it works for them and they can live comfortably with the side 

effects.  Whatever floats your boat, eh?  I took Symmetrel and it was a 

disaster for me...but Baclofen worked.  For another, it is the opposite.  I 

think that it is terrific that we can share both our positive and negative 

reactions for the benefit of others...just not push our conclusions off on 

others.  I am so glad to hear that the 4-AP has worked so well for you, Pat!

Karlyn

 

> I don't know how to reach the originator of this thread but it is only 

> fair to say 4-AP has helped many of us with MS when nothing else has.  I 

> feel it is unkind to downplay something that pwms are getting help from.  

> For example, betaseron may have made you deathly ill while it has helped 

> someone else, or IV Sol, or IVIg, etc.  I don't think we are here to 

> proselatize (sp?) about the strengths/weaknesses of drugs for pwms...many 

> of the drug companies pay millions to do that.  What we do best is share 

> our experiences.  4-AP gave me back a full point on the EDSS and 

> continues to abolish fatique and allow much better stamina and use of 

> upper body....so I can write this note....3 years of use later.  And I'm 

> not brain dead. 

>                                                                           

>                        Pat in Seattle 

> 

> 



From alt.support.mult-sclerosis Tue Mar 25 16:08:07 1997
From: clybro@aol.com (Clybro)
Date: 24 Mar 1997 04:11:14 GMT
Newsgroups: alt.support.mult-sclerosis
Subject: Re: Marriage breakdown st
Status: O
X-Status: 

I got married to my husband 11 years ago and he had ms
when we married.  he was in alot better shape than now.

i think that our relationship is a strong one also, but we almost
didn't make it a couple of years ago.  i had worked full-time and have
a beautiful daughter almost in her teens, and was full-time caregiver
when i'd get home from work, and had no help picking up or with
any other house work during the day, my husband's disease has
progressed to the point that he is unable to do chores, or even
dress himself.  i think something happened to me, i couldn't do it
anymore.  i lost my job, which was a blessing in disguise,
and i wanted more than anything to run away from all the responsibility at
home, so i actually left him for a couple of months,
and only came for visits, no work.  he hired personal assistants
and that has eased alot of the burden.  i come back home and
started the tedious task of redefining my role as wife/mother vs.
caregiver.  i found i could not do both.  when he'd fall i could not
pick him up,  it would reduse me to tears alot.  finally after months
i think that i have reorganized my feelings, and have come to the
conclusion, that i want to be his wife still, and am able(emotionally)
to handle dressing him, etc. on a part-time basis.  things are
finally settling down, and we love each other alot.  the pain of watching
someone you love fade away a little at a time sometimes
is too much,  then i remember it is him that is living it,  & i'm only
living around it.  but i have a life too, and since i realized that
we have been doing much better.  it took alot for me to allow
myself certain spaces.  personal assistants are a drag to have
around sometimes, and you almost have to take who you can get,
but they are allowing our marriage to survive.  

here's sort of an aside, clyde (my husband)  has had ms going on
25 years, he's almost 44,  he was a musician and can still sing.
he made a beautiful CD and it is for sale, if anyone would like one.
his e-mail is CLYBRO@aol  hope somebody got something
out of my ramblings,  i think it was healthy. thanks


From alt.support.mult-sclerosis Wed Mar 26 16:50:56 1997
From: carneen@aol.com (Carneen)
Date: 24 Mar 1997 23:20:02 GMT
Newsgroups: alt.support.mult-sclerosis
Subject: Re: Should Chronic Progressive use Avonex?
Status: O
X-Status: 

I have CP MS and took Beta Seron for two years before switching to Avonex
in August.  My migrain headaches stopped when I began Beta Seron, but my
MS been getting continually worse.  I don't know if my decline would bave
been swifter without the interferon.......that's the rub.   

I will continue to take Avonex until something better comes along.  I am
trying to get my insurance to pay for Cladribine.

I love to hear from others with CP MS.  Please email me at

Carneen@aol.com

alt.support.multi-sclerosis


From alt.support.mult-sclerosis Sat Mar 29 11:16:30 1997
From: SHAZAM@mail.IDS.NET (Al Mangarelli)
Date: Fri, 28 Mar 1997 01:16:23 GMT
Newsgroups: alt.support.mult-sclerosis
Subject: Re: Cytoxan
Status: O
X-Status: 


Brigham & Womens Clinical MS Unit still uses Cytoxan as procedure in
cpms in a modified form. Dr. David Hafler improved it's functionality
and many patients in the uniit have been successfully using it for
years now. many have not progressed. 

However it's still a prety heavy duty way to go.

Al
---

On Thu, 27 Mar 1997 18:50:35 GMT, cczimmer@mindspring.com (Carolyn C.
Zimmer) wrote:

>Jackie Ferguson <jackferg@worldnet.att.net> wrote:
>
>>kenneth.quinn wrote:
>>Well ... yes and no.  I haven't actually read the latest studies, but I
>>heard that Cytoxan proved to be no better than the controls.  It was
>>Howard Weiner, MD, the MS Guru from Boston who did a well known study @
>>15 years ago that showed promise for Cytoxan (an "old" cancer drug and
>>powerful immunosuppressant) ... this was disproved by a study which I
>>think was done in Canada.
>
>Cytoxan was the immunosupressant of choice a few years ago.  They are
>now using Immurex (or Immuran or something like that) more.  Only for
>the progressives (either CP or 2P).
>
>Z
>
>http://www.mindspring.com/~cczimmer/
>+------------------------------------------------------------------------+
>+ Carolyn C. Zimmer       | "I've been warped by the rain,               |
>+ Duluth, GA              |  driven by the snow, I'm drunk and dirty,    |
>+ cczimmer@mindspring.com |  don't you know, But I'm still...willin'"    |
>+ STANDARD DISCLAIMER     |                               Lowell George  |
>+------------------------------------------------------------------------+
>


From alt.support.mult-sclerosis Sun Mar 30 16:05:38 1997
From: watkinsksg@aol.com (Michael Watkins)
Date: 29 Mar 1997 18:05:47 GMT
Newsgroups: alt.support.mult-sclerosis
Subject: Neurocrine Biosciences Phase I trial
Status: O
X-Status: 


Neurocrine Biosciences has completed
a Phase I clinical trial of a compound known as
NBI-5788 for treatment of MS.
This trial was conducted in concert with Novartis Pharma AG.
It involved 30 patients five medical centers in the United States and
Canada. The focus of the Phase I study was on safety assessment, and an
independent board recommended progression to Phase II studies
of treatment effects for relapsing/remitting and CP MS patients.
The RR trial is expected to begin in mid-1997 and the CP trial later in
the year.

***
Copyright -- Permission is granted to
everyone to freely copy, post and otherwise reproduce this
message so long as the entire message is copied

To subscribe to the autoimmune_research e-mail distribution list,
simply send an e-mail to michael_watkins@harvard.edu.
If you come across any interesting information
related to autoimmunity, please send it to
the same address.

From alt.support.mult-sclerosis Mon Mar 31 12:12:00 1997
From: LaVonne Murphy <mscansd2@worldnet.att.net>
Date: Sat, 29 Mar 1997 19:31:25 -0800
Newsgroups: alt.support.mult-sclerosis
Subject: Re: 4AP CAUTION!!!
Status: O
X-Status: 

Pat Logan wrote:
> 
> I don't know how to reach the originator of this thread but it is only
> fair to say 4-AP has helped many of us with MS when nothing else has.  I
> feel it is unkind to downplay something that pwms are getting help from.
(snip)
 What we do best is share
> our experiences.  4-AP gave me back a full point on the EDSS and
> continues to abolish fatique and allow much better stamina and use of
> upper body....so I can write this note....3 years of use later.  And I'm
> not brain dead.


Pat

I'm sorry I did not answer this post earlier.  Have been out of reach of 
my computer for a week or I would not have let you stew all this time.

I did the original post.  I know someone who is gathering info on 4AP and 
just reported what she told me.  MS Clinics are reporting an increased 
number of people coming in to their emergency rooms with seizures because 
they have taken 4AP.  Also, the study has been stopped again because the 
drug is unstable and increases in strength.  This has been proven with 
lab testing of the drug that is out there.  It had nothing to do with the 
drug company that made the drug for the study.  The docs monitoring the 
study did it.  Because they beleive this drug to be helpful and want to 
continue the study, they sent the drug company back to the drawingboard 
to find something to make the drug more stable.

Nobody said anything about brain dead.  I would like to add here, that if 
you are on the drug and have had good results, stay on the drug at the 
same dose and do not switch your source.

The message was meant as a caution that should be looked at and not as a 
death sentence.

               L

From alt.support.mult-sclerosis Wed Apr  2 10:29:36 1997
From: Ann Manasreh <cattails@flash.net>
Date: Tue, 01 Apr 1997 09:01:48 -0700
Newsgroups: alt.support.mult-sclerosis
Subject: Hu23F2G study
Status: O
X-Status: 

My neuro, Dr. Corrie Ford, is beginning the Hu23F2G study at the 
University of New Mexico.  It's only a year long.  It's divided up into 
4 groups--2 levels of Hu23F2G, IVMP, and a placebo.  He has the right to 
intervene with IVMP if it becomes necessary.  The first week requires 2 
lumbar puctures.  I don't know if there are more of those to come.  I 
don't know the other study site locations, but I can try to find out.

No, I'm not participating.  I had natural childbirth twice to avoid 
having my spine messed with.  But I wanted to tell that other things 
happen in Albuquerque besides murders.

From alt.support.mult-sclerosis Thu Apr  3 10:05:59 1997
From: Ann Manasreh <cattails@flash.net>
Date: Tue, 01 Apr 1997 15:34:38 -0700
Newsgroups: alt.support.mult-sclerosis
Subject: Re: Hu23F2G study
Status: O
X-Status: 

Sorry, I don't know the common name of this drug.  And I'm quoting 
directly from Jean Sumption's International MS Support Foundation 
newsletter.  ICOS (?) believes Hu23F2G may reduce the severity and 
length of acute MS exacerbations by preventing white blood cells' 
ability to bind to vascular endotheliun in the brain and spinal cord.  
They speculate this action will interfere with their mobility into these 
tissues.  Should this happen, inflammation may resolve sooner and 
neurological damage may be reduced.

This is Ann speaking:  Since the drug does it's work in the spinal cord, 
this is the why of the lumbar puncture (aka spinal tap).  Basically it 
seems to be a possible replacement for IVMP.  Would it have similar 
side-effects?  Is it a steroid?  I don't know.  But there are so many 
complaints and fears about IVMP, that it would be good to find a drug to 
replace it.

Ann

From alt.support.mult-sclerosis Sun Apr  6 21:02:07 1997
From: Gerald Gold <gerry@yorku.ca>
Date: Fri, 4 Apr 1997 20:22:38 -0500
Newsgroups: alt.support.mult-sclerosis
Subject: Re: Methotrexate
Status: O
X-Status: 

Bill McCartney wrote:
>
>         A friend has just begun using Methotrexate.  She is now in an
> advanced state of MS and is                              wondering what to
> expect.
>
>         Anyone taking Methotrexate or familiar wi h the drug please respond.
>
>         Benefits?, Side effects?, Dose?, etc.
>
>                                 Thanks in advance,
>
>        Bill - Levittown, NY
> EMail  Hotwheel@specdata.com
>
>            ~|_
>             (_)\_
Bill, I have been taking methotrexate for about one year and I
supplement that with a monthly injection of vitamin B 12. I can still
use my fingers but I seem to be gradually losing vat as well. Every
month my blood levels are monitored.
but I cannot definitely say that methotrexate has made a difference.
Maybe . Gerry
--
Gerald Gold
Department of Anthropology
York University
North York, Ontario
M3J 1P3, Canada

From alt.support.mult-sclerosis Sun Apr  6 21:03:44 1997
From: jshore@eazy.net (Jeffrey Shore)
Date: Sat, 05 Apr 97 10:58:29 GMT
Newsgroups: alt.support.mult-sclerosis
Subject: Re: Methotrexate
Status: O
X-Status: 

In article <3344759C.5AD6@EriNet.com>,
   Paul/Joyce Eberl <eberph@ERINET.COM> wrote:
> ... The only "pain" is that I have to have bloodwork 
> done every 3 weeks to make sure that the methotrexate
> isn't over-suppressing my immune system.

Mmmmmm. I suppose it is possible some of your bloodwork
is for that ... but the most common testing is done to ensure
that liver functions are not being adversely impacted, and
that the level of methx in your system is not too high. It
is normally maintained at a significantly lower level than
it would be, say, for someone on chemotherapy. The average
half-life level can be kept too high (a greater probability 
of liver damage or reduced red blood cell production) whcich
can occur if you are also taking something like salicylates. 
Aspirin or compounds that have the same effect block filtering 
done by the kidneys which in turn keeps the level too high.

The three-week or generally frequent monitoring is also usually
reduced gradually to quarterly bloodwork once your methx levels
are stabilized though more frequent tests certainly don't hurt.

FYI I was on methx (10 mg weekly) for 2.5 years with very nice
results until it suddenly stopped having an effect. Fortunately
Avonex had been approved for general usage a few months earlier
so my docs shifted me to that after a 6-week "de-tox" to flush
the remaining methx from my system. I've now been on Avonex for
6 months and it appears to be taking effect and without any
apparent side-effects so far (except for this little green
appendage that seems to be growing out of my forehead ....)

Jeff Shore
"The gimp with an attitude ...." :)
jshore@eazy.net


From alt.support.mult-sclerosis Tue Apr  8 18:02:19 1997
From: Jack Wilson <jwilson@liii.com>
Date: Sat, 05 Apr 1997 16:32:50 -0500
Newsgroups: alt.support.mult-sclerosis
Subject: Linomide cancelled
Status: O
X-Status: 

I was in the Linomide study. That large study was cancelled. Has anyone
heard why?  There were 600 in the study. To cancell it is a major
event.  I had a heart attack while on it. I wonder if others did also.

From alt.support.mult-sclerosis Tue Apr  8 18:06:37 1997
From: Bertel Stenius <bertel@jbs.pp.fi>
Date: Sun, 06 Apr 1997 15:02:04 +0300
Newsgroups: alt.support.mult-sclerosis
Subject: 5 M Man Aapo
Status: O
X-Status: 

Hi folks,

Aapo Halko is a well-known member of our group and editor of the MS Web
site that many of you read. It might be of interest to you that the last
issue of Avain ("The Key"), the journal of the Finnish MS Society,
carries a feature story about him: two pages, with one large picture and
one small one.
	Aapo, 33, is introduced as "the man of the five M": (1) MS, (2) maths,
(3) Mac (Macintosh computer), (4) music, and (5) me.
	M #1: Aapo had his first symptoms in 1979, but they were more or less
dismissed as imaginary illness. In 1990 the disease got aggressive. In
1994 Aapo was offered an electrical wheel-chair, which he accepted. He
never regretted the decision.
	M #2: That maths is Aapo's subject is known in this group since Aapo
acquired his doctor's degree. He wrote his dissertation on a branch of
the theory of sets. He is now a researcher at the University of
Helsinki.
	M #3: The Mac is the vehicle with which Alpo travels the world. He
thinks it's handicap friendly. A member of this support group since the
year 1992, Aapo specializes in collecting scientific materials about MS
for his Web site. The site has about 4000 visitors a month.
	M #4: Maths and music are generally close to each other, and so they
are in Aapo's life as well. After having lost feel and dexterity Aapo
exchanged the guitar for the electric piano, which, however, now runs
the risk of being taken over by the daughters.
	M #5: Me? The author of the story says, rightly, that some of this "me"
can be found between the lines by the one who knows to interpret in the
right way what he or she reads, but alas, this note is just a
minimalistic summary. You must content yourself with Aapo's postings and
his Web site.
	Aapo is married to Heli, a psychologist, and has two daughters, Noona,
6, and Ida, 2.
	As I wrote in an article some time ago, Aapo was the one who pointed me
in the direction of this support group. In Avain, I read an article
which Aapo had written about MS and the Internet. He helped me on the
phone with a technical problem, and well, here I am.

Bertel in Helsinki

From alt.support.mult-sclerosis Sat Apr 12 12:04:17 1997
From: costa@erg.sri.com
Date: Fri, 11 Apr 1997 02:49:37 GMT
Newsgroups: alt.support.mult-sclerosis
Subject: Re: cladribine
Status: O
X-Status: 

"mcooper" <mcooper@peganet.com> wrote:

>I'm taking cladribine and would like to write to anyone else who is or has
>taken it.

>					Mel Cooper

I've been taking it for 4 months. My dose is .07 mg./kg by
subcutaneous injection once a day for five days.  I repeat this every
4 weeks.  I would have been due for my fifth cycle but my doctor
decided against it based on my lymphocyte count.  He said it was
already low enough.

I beleive the progression of my MS has slowed considerably since I
began treatment. I may even have stabilized.  I consider this notable
considering the rate of progression in the year before I began
treatment.    So far I haven't noticed any obvious reversal or
improvement in symptoms.  But, if cladribine has indeed stabilized me
and keeps me stable, it was well worth the expense and effort.

 I was taking methotrexate for 9 months prior to the cladriibine.  As
far a I could tell it was no help, I could easily see progression on a

monthly basis.

Prior to the methotrexate I was  on BetaSeron for 2 years  It seemed
to slow the progression for a while.  Whereas, the cladribine seems to
be halting progression.

Can you let me know more about your experiences.

Ed  Costa



From alt.support.mult-sclerosis Sat Apr 12 20:26:13 1997
From: "hnspjotr" <hnspjotr@pi.net>
Date: 11 Apr 1997 17:41:47 GMT
Newsgroups: alt.support.mult-sclerosis
Subject: pray for my brother
Status: O
X-Status: 

Hello everybody,

Right now, my brother is dying of MS. He's only 35 years old, and he had
not yet lived his life in full. He is now very weak, and he has a starting
pneumonia. He can't do anything by himself anymore, not even swallow, so we
had to take him to a hospital. There we decided that it's no use to use
medication against his pneumonia, because he has made clear some time ago
that he doesn't want to continue living under these cicumstances. Now I
know that there is a lot of people who can't deal with this, but it is the
only way. We have to respect that choice. It is hard, so very hard to go to
sleep at night knowing your brother is dying. My father has cried more
these past few days then he has done in the rest of his life. So we wait
for the inevitable thing to happen. We don't know when it will happen, but
it will, and soon. 

So please pray for him. I'm not religious, but I'm praying untill my throat
is sore. It's the positive thought behind a prayer that counts..

thank you,

Hans-Peter
hnspjotr@pi.net
 

From alt.support.mult-sclerosis Tue Apr 15 11:59:03 1997
From: Carol Crandall <ccrand01@MAIL.COIN.MISSOURI.EDU>
Date: Sun, 13 Apr 1997 23:01:17 -0500
Newsgroups: alt.support.mult-sclerosis
Subject: Re: Experience with Cytoxan and other Chemotherapy agents
Status: O
X-Status: 

I have had the experience of having Cytoxan.  I was on Cytoxan for a
period of 9 months.  It was terrible.  The only good thing about it was
that I lost some weight that I needed to lose.  I was sick at my stomach
frequently while taking the Cytoxan.  My veins have gotten so bad from
all the blood drawn and all the blood taken for bloodwork that I actually
have knots in the veins.

I was so sick from the Cytoxan one month that they had to admit me to the
hospital for three days.  I couldn't even keep 7-Up down.  I had
dehydrated when they admitted me.

I went through the hell of this drug for 9 months only to be finally
taken off of it because it was not helping the MS at all.  My heart
definitely goes out to cancer patients who take a much higher dose than
what I was given.  I was really glad to get off of that "poison".

I am still taking an oral chemo drug, Imuran, but it only has an
occasional effect of making me slightly nauseated.  It isn't anything
that I can't handle.

I wish you the best of luck.  Carol



Carol Crandall, ART, RRA
ccrand01@mail.coin.missouri.edu

From alt.support.mult-sclerosis Wed Apr 23 15:17:22 1997
From: ahalko@cc.helsinki.fi (Aapo Halko)
Date: 22 Apr 1997 16:03:20 +0300
Newsgroups: alt.support.mult-sclerosis
Subject: Oral myelin trial disappointment
Status: O
X-Status: 

Disappointing results from clinical trial of oral myelin for rrMS:

http://www.nmss.org/msinfo/current_research/updates/RMP9717.html

    April 21, 1997

        Disappointing results from clinical trial of oral myelin for
                           relapsing-remitting MS

     _________________________________________________________________

   On April 21, 1997, AutoImmune Inc. (Lexington, MA) released
   preliminary results from their two-year, phase III clinical trial of
   Myloral., a preparation of bovine (cow) myelin given orally (by
   mouth). Data indicate that there was no difference in frequency of
   relapses or progression of disability between those taking the drug
   and those who received the inactive placebo. Brain magnetic resonance
   images (MRI), taken at intervals throughout the trial from all
   participants, have not been completely analyzed. Safety data showed
   that the drug had no adverse effects.

   The clinical trial involved some 500 people with well-defined
   relapsing-remitting multiple sclerosis. More than half of these
   individuals in the study received daily doses of Myloral. the rest
   received an inactive placebo. The study was double-blinded so that
   neither the individuals in it, nor the physicians evaluating them,
   knew who received the active drug. Participants in the trial were
   assessed every three months throughout the study.

   This early information was released by the company to comply with
   Federal Securities and Exchange Commission regulations concerning
   information for investors in publicly held companies. Additional
   analysis of data will glean as much as possible from these
   disappointing results.

   ) 1997 The National Multiple Sclerosis Society
   checked: April 1997

-- 
Aapo Halko  <aapo.halko@helsinki.fi>              *         |_
     http://www.helsinki.fi/~ahalko/ms.html       *    ___  O o
A www page that collects MS links on the Internet.*

From alt.support.mult-sclerosis Tue Apr 29 10:56:01 1997
From: Carol Crandall <ccrand01@MAIL.COIN.MISSOURI.EDU>
Date: Fri, 25 Apr 1997 16:21:55 -0500
Newsgroups: alt.support.mult-sclerosis
Subject: Re: IVIG
Status: RO
X-Status: 

Ann,

I am not currently using immunoglobulin. The treatment course for it was
5 days inpatient IV IG initially and then once every other month on an
outpatient basis for one year.  The inital 5 days that I had the IVIG as
an inpatient, I also was given 20 doses of IV SoluMedrol.  I took the IVIG
along with an oral chemotherapy drug, Imuran.  I am still taking the Imuran.


It has stabilized the progress to where I am not having exacerbations as
frequently as I was.  I still have them, but just not as frequent.  It
does not undo any damage that has previously occurred.

I am thankful that I don't have the exacerbations as frequent as I
was.

I hope this has helped you.  If you have any other questions, please feel
free to ask.  I will try to answer them for you, but you must remember
that I am by no means an expert.  Carol


Carol Crandall, ART, RRA
ccrand01@mail.coin.missouri.edu


On Fri, 25 Apr 1997, Ann Manasreh wrote:

> Hello Carol,
>
> I think I remember that you are using immunoglobin.  How is that going?
>  We'd all love to hear about that.
>
> Ann
>

From alt.support.mult-sclerosis Fri May  2 19:28:05 1997
From: Paul Bruce <Chanteline@AOL.COM>
Date: Tue, 29 Apr 1997 16:01:49 -0400
Newsgroups: alt.support.mult-sclerosis
Subject: NewsFlash - Therapy Update from the AAN meeting in Boston
Status: O
X-Status: 

Everyone,
This was posted by sumption@aspin.asu.edu  Jean Sumption
 Director,msnews@aspin.asu.edu.

Paul Bruce

In a message dated 97-04-29 15:21:46 EDT, Jean Sumption wrote:

<< Subj:        NewsFlash
 Date:  97-04-29 15:21:46 EDT
 From:  sumption@aspin.asu.edu
 Sender:        owner-msnews@aspin.asu.edu
 To:    msnews@aspin.asu.edu

 Therapy Update from the AAN meeting in Boston.

 Boston, MA.  This year's recipient of the prestigious Frank H. Netter
 Lecture, Barry G. W. Arnason, MD, told the audience at the Presidential
 Plenary Session that, after more than a century without an effective
 therapy for multiple sclerosis, neurologists now find themselves with
 three drugs that have recently been approved for the treatment of this
 demyelinating disease.  Moreover, all three agents--Avonex, Betaseron,
 Copaxone--exert a beneficial effect on the attack frequency of multiple
 sclerosis.  Allowing for differences in patient groups, study end points,
 and other parameters in the published pivotal trials, all three drugs
 reduce the relapse rate by about on third.

 However, sad Dr. Arnason of the University of Chicago, where he was
 chairman of the Neurology Department for 20 years and is currently the
 James Nelson and Anna Louise Raymond Professor of Neurology, "a 30%
 reduction in attack frequency, while substantial and highly significant,
 is nonetheless not good enough."  Dr. Arnason noted that this may actually
 understate the efficacy of these treatments, since for Betaseron at least,
 the reduction in major attacks was 50% and there was a 60% reduction in
 the number of days patients spent experiencing attacks.  Nevertheless,
 according to Dr. Arnason, there is a need to do better.

 Dr. Arnason suggested that one approach to better treatment might be
 combination therapy to potentiate the ability of interferon-beta to
 correct certain immune system abnormalities exhibited by patients with
 multiple sclerosis, such as decreased suppressor cell function, which is
 partially restored by Betaseron both in vitro and in vivo.  One such
 co-agent to test would be transretinoic acid, an approved drug for the
 treatment of psoriasis, which has a different side effect profile than
 that of Betaseron.  When combined with IFN-B in vitro, this agent
 synergistically potentiates the ability of IFN-B to augment suppressor
 cell function.  Based on this synergism, Dr. Arnason's group is now
 combining transretinoic acid with Betaseron in a pilot clinical trial.

 Immune function in patients with multiple sclerosis before and after
 treatment with IFN-B was also the focus of four additional presentations,
 three of which dealt with neutralizing antibody (NAb) formation.  Richard
 A. Rudick, MD, Cleveland Clinic Foundation, presented results obtained
 with a new method for detecting NAbs in patients treated with Avonex, some
 of whom had previously been treated with Betaseron.    Using a cutoff
 titer of >20 to define NAb positivity, the incidence of NAbs against
 Avonex after 1 year in this open-label study was <10%, considerably lower
 than the rates in the published double-blind, phase III trial.  However,
 at titers >20, NAbs persisted in serial serum samples 90% of the time if
 patients were continued on open label Avonex.  Reanalysis of the phase III
 samples using the new immunoassay suggests a trend toward reduced clinical
 and MRI efficacy in patients with titers >20.  Furthermore, Dr. Rudick
 reported that there was a significant reduction in NAb positivity when
 patients were switched from Betaseron to Avonex.  However, Peter A.
 Calabresi, MD, National Institutes of Health, Bethesda, Maryland, then
 presented data showing that, with Betaseron, >50% of NAb-positive patients
 revert to negative while being maintained on Betaseron, and NAbs to
 Betaseron persisted in only 15% of patients.  He believes that the
 correlation between the effectiveness of the treatment and the presence of
 antibodies was not clear-cut.

 Data presented by Joel J. F Oger, MD, University of British Columbia,
 Vancouver, British Columbia, suggest that there may be a biological
 difference between patients who form antibodies and those who do not.
 Those who form NAbs may have a more vigorous immune system, as
 demonstrated by high IgG secretion in the response to mitogen stimulation
 in vitro, and may be less responsive to current therapies.  Another
 potential mechanism for treatment failure was presented by John H. Uhm,
 MD, University of Montreal, Montreal, Quebec, who discussed the role of
 tissue inhibitor of metalloproteinase in reducing T-cell migration.

 Commenting on these presentations, Donald W. Paty, MD, University of
 British Columbia, Vancouver, British Columbia, stated that although
 considerable data are being generated to suggest that NAbs have an effect
 on the ability to treat multiple sclerosis with the interferons, it is not
 a consistent effect.  Some patients who form antibodies to IFN-B remain
 responsive to the drug, while some who do not form antibodies are
 unresponsive to IFN-B.  Thus, Dr Paty believes, there are still many
 unanswered questions regarding the biologic effect of NAbs.

 From another clinician's point of view, Jack S. Burks, MD, Denver
 Colorado, believes that until there is further clarification of the
 conflicting data regarding responsiveness to therapy in both the presence
 and absence of NAbs, antibodies should not be the single factor that
 determines whether a patient's therapy should be continued or switched.
 Patients doing poorly should have their medication switched even in the
 absence of NAbs, but if they are doing well they should be continued on
 the same medication.  After all, said Dr. Burks, neurologists "must treat
 the patient, not the antibody."  Although antibodies and other mechanisms
 leading to treatment failure remain debatable issues, the focus of the
 experts at the meeting was on the now established value of the three
 approved agents for the therapy of relapsing forms of multiple
 sclerosis.


 Yours in hope and good thoughts,

 Jean Sumption
 Director                                 Smile and Warm the World
 __________________________ >>

From alt.support.mult-sclerosis Mon May  5 13:08:36 1997
From: langs006@maroon.tc.umn.edu (Dave Langsdale)
Date: Sun, 04 May 1997 09:06:31 GMT
Newsgroups: alt.support.mult-sclerosis
Subject: Methotrexate
Status: O
X-Status: 

After 22 years of cpms, my current va Dr has decided that I should
start on Methotrexate at 2.5 mg 3 times per week.

My question:  I'm already full time elec w/c with use of only one
hand...and manage my life quite nicely with the help of my wife. 
...the absolute last thing I need to further complicate my life is
diarhea <unable to transfer unassisted>.

Is this a real problem with this med?

Dave


From alt.support.mult-sclerosis Sat May 10 22:42:16 1997
From: Elizabeth Cook <ehcook@GN-INTL.NET>
Date: Tue, 6 May 1997 21:05:13 -0400
Newsgroups: alt.support.mult-sclerosis
Subject: 1997 NMSS Teleconference
Status: O
X-Status: 

I attended the 1977 MS teleconference  on MS Treatment.I was pleased to
hear the most recent evaluations of Linomide, Myloral, Leustatin, and
sulfosalazine.  Linomide was withdarwn from clinical trials.  It was
associated with serositis and recently myocardial infarction (heart attack)
occurence, oral myelin was ineffective, leustatin
(cladribin) bit the dust also.  My mind wandered as something was said
about methotrexate.  The presentor was JS Wolinsky,MD and Emily Cerretta
MSN.  There are different presentors as the show appears in different areas
of the US.  This one seemed to be broadcast to mostly Eastern sites.  Hope
this helps inform.

From alt.support.mult-sclerosis Sun May 11 17:40:49 1997
From: chanteline@aol.com (Chanteline)
Date: 8 May 1997 21:10:49 GMT
Newsgroups: alt.support.mult-sclerosis
Subject: New drug offers hope for ms patients -- 4-aminopyridine
Status: O
X-Status: 

A study of 10 ms patients suggests that the drug 4-aminopyridine can
improve walking speed, enable better grip strength and heightened overall
strength.

The exciting part of the research results is that the drug improves the
most disabling symptoms for ms patients. Dr. Steven Schwid, University of
Rochester, was a co-author of the report.

Paul Bruce

Paul From IL USA
chanteline@aol.com

From alt.support.mult-sclerosis Mon May 12 13:34:03 1997
From: steve@tropheus.demon.co.uk (Stephen Wolstenholme)
Date: Sat, 10 May 1997 16:38:33 GMT
Newsgroups: alt.support.mult-sclerosis
Subject: My worst and best foods.
Status: O
X-Status: 

I've now been analysing how foods, drinks and supplements interact
with my MS symptoms for 290 days. I think it's about time the I posted
the worst and best items. We may be able to identify some items in
common. I've only included the items that stay at the extremes of my
food score lists.

Worst 20 items. Worst first:

corn oil, chilli, sweet peppers, ginkgo biloba, iron tablets,
margarine, garlic, sweet pickle, celery, paprika, vinegar, rye,
lettuce, salt, Trocomare, decaf coffee, bread, Guarana, lime pickle,
hazel nuts.

Best 20 items. Best first:

onion, Anadin Extra, potato cake, potato salad, whiskey, cole slaw,
grapeseed oil, yogurt, apple, brazil nuts, mushrooms, pasta, cinnamon,
Rice Dream, Naudicelle Plus, soya oil, vit B complex, grapes, tea,
safflower oil.


Steve
--------------------------------------------------------
Stephen Wolstenholme: Author of Neural Network Shareware
Neural Planner - Windows neural network system
NeuroDiet - Windows 95 health and diet planner
web page: http://www.tropheus.demon.co.uk

From alt.support.mult-sclerosis Fri May 16 11:26:34 1997
From: Chanoch Weil <ccanacw@aluf.technion.ac.il>
Date: Thu, 8 May 1997 14:17:54 +0300
Newsgroups: alt.support.mult-sclerosis
Subject: Voice recognition software
Status: O
X-Status: 

The following article is by Bruce Couper:


~Date: Fri, 2 May 1997 16:29:29 -0400
~From: Bruce Couper <bcouper@inforamp.net>
~Reply-To: MS Canada List <ms_can-l@oise.utoronto.ca>
To: MS Canada List <ms_can-l@oise.utoronto.ca>
~Subject: MSC: Finally - that article I promised on voice input

Hi folks

I'm finally getting around to that article on the voice-recognition system
I'm using, Kurzweil VoicePad Pro.  Everything seems to be taking longer
these days.  I know there are messages on the list I should be responding
to, but today this has priority.


Background:

The explosive growth of the Internet has opened a new world for many folks
with MS and others isolated by disease and disability.  As wonderful as
this is, the very tools for its use can be an impediment or barrier for
some of us.  There are always solutions, of course -- some examples are
larger screens or voice output for folks with limited or no vision and
enhanced keyboards or voice input for folks who find it difficult for
impossible to use a standard keyboard.

Some solutions, such as "sticky-key" programs or settings are simple and
free.  Others, such as very large displays and voice input can be quite
expensive, though various provincial assistance programs may help.  The
solution I'll write about here is one which is very reasonably priced and
might meet the needs of those of us who can still use a mouse (or
trackball) and/or keyboard to a very limited degree, but who might benefit
from voice input for writing.

Please note that the software I will mention are the "lite" or least
expensive versions.  The "full" versions do very much more, at much greater
cost.  For example, Dragon Systems has a new product which is supposed to
allow natural, continuous speech, without the short pauses required by
other systems.  It and the more powerful versions of voice-recognition
software from other companies also allow dictation into any application and
control of the Windows environment (such as menus, dialogue boxes etc..).


The Important Bits:

I'm "writing" this with Kurzweil VoicePad Pro, a voice-recognition word
processor that allows me to write anything and everything without touching
a key.  I speak and the words appear on the screen at a rate that's many
times faster than my last few years keying with one finger; at least as
fast, in fact, as I could type when I was young and a fairly quick
touch-typist.

Voice-recognition software has been available for a few years now, getting
better as both the software improved and computers became more powerful.
Some of us have watched, wishing we could afford both the software and
hardware.  Then, some of us have slowly acquired faster hardware but have
balked at the high cost of the software, often in the $800 to $1000+ range.

If, like me, you can still use a mouse or trackball and keyboard to at
least the limited degree necessary to run programs, manage files etc. and
really only need or want voice input for writing things like email, or want
a simpler and less expensive step before buying "full" voice-recognition
software that does almost everything, then read on.

I've been looking at voice input for some time, even going to a friend's
house to try his.  I've seen the excellent DragonDictate and IBM VoiceType
for Windows 95.  Both work well (with DragonDictate being the more popular,
I believe, and seeming to have more complete control over the Windows
environment, against IBM's impressive context-sensitive recognition), but
both are far more expensive than I can afford.  Provincial assistance
programs are great, but the waiting list is long.

I found an alternative.  Kurzweil VoicePad Pro does everything I currently
need and does it very well at a Canadian price of $119 (when I bought
mine).  Much more attractive.  Not only that, I was able to download a demo
version to try out.  While recognition accuracy is at best abysmal without
a high-quality microphone, the demo shows well how the software works.  I
ordered the commercial version from a Canadian supplier.  Additionally, if
I do decide to upgrade to their more expensive version which works with
other software, I can do so at a savings and in any case their more
expensive product is in the range of half the price of their competitors.

I don't feel qualified to compare the various products now available.  Both
IBM and Dragon Systems have "lite" versions available, priced close to
Kurzweil VoicePad Pro.  My guess is that it's a matter of personal
preference.  Certainly, one can use a search engine to check Usenet
messages people are writing about those products.  I can tell you that the
IBM product, VoiceType Simply Speaking, like the Kurzweil product, operates
within its own Wordpad-like word processor.  As I understand it, the Dragon
Systems products, called I think, "Singles", operate with specific
applications.

I find the Kurzweil product very easy and intuitive to use.  Rather than
try to explain precisely how it works, though, I'll leave it to anyone
interested to try the demo version or email me questions.  Instead, I'll
give you an example of my using it, and I'll add some things I think folks
should consider before buying.

I start by first running VoicePad Pro.  It takes a few moments to start,
after which I just leave it in the background.

When I've read an email message I wish to respond to, in my email program,
I click the reply button which then displays the original message in quoted
form.  I right-click on the message body and click Select All from the
popup menu, then right-click and select Cut, cutting the text to the
clipboard.  I then switch to VoicePad Pro and paste the quoted message
there.  The rest is done just as we all do, except by voice input rather
than using the keyboard.

When the message is completed, I say "cut-all" which executes a command
I've created in VoicePad Pro which cuts all the text of the reply to the
clipboard and shrinks the size of the VoicePad Pro window.  I then
right-click on the exposed part of my original mail program reply window
and click Paste.  Done.  It's not quite as convenient as dictating directly
into the original application, but the extra steps make only a few moments.


Those Considerations:

Accuracy --
The various products claim 90% accuracy, initially, with final accuracy of
97% or better after extended use or "enrollment".  I've found this to be a
tad optimistic with VoicePad Pro, but good, only when I'm well-rested and
quite alert.  I can speak quite clearly under those conditions, but as MS
fatigue sets in, my volume drops out and I become less careful, more apt to
not leave the sight pause required between words and less consistent in my
enunciation.  Therefore, I would suggest that folks need to be able to
speak fairly clearly and quite consistently.  Since MS sometimes affects
the clarity of speech, this can be a very real problem.

Hardware requirements --
While Kurzweil VoicePad Pro claims it will run on a 486-75, under Windows
3.1x, I rather expect that all available products are more realistically
run on a Pentium-class computer under Windows 95.  My other guess is that
16 megabytes of RAM would be a realistic minimum for reasonable speed.  You
also need a compatible sound card (it looks like they all work with a broad
range, with Sound Blaster 16 being the standard).

Which is "best" --
I don't know.  As I suggested earlier, it's probably a matter of personal
preference.  However, IBM does offer to accept product returns within a
specified time.  I don't know that they'd care for my suggesting this, but
since the very same microphone is included with both IBM VoiceType Simply
Speaking and Kurzweil VoicePad Pro, if one purchased the IBM product and
had any doubt about its appropriateness, one could try the demo of the
Kurzweil product and at least compare them.  I'm sorry, but I don't know
the return policies, if there are any, for either Kurzweil products or
Dragon Systems products.  You might want to ask.

A personal observation --
I've been doing this for some time, now, and am finally comfortable with
it; "comfortable", not in the sense of being able to use this software, of
being able to dictate words which appear on the screen, but comfortable in
another way I hadn't anticipated before starting.

I've spent a good many years "typing", then keying, my thoughts.  When
word-processors arrived, editing became easy and words thrown out too
carelessly could easily be rearranged.  Talking into a microphone was
suddenly very different.  I can't tell you why, I can just tell you that,
aside from the time it took to learn to use this, it took quite a while to
feel comfortable dictating.  Different brain pathways?

Finally --
There it is, folks.  I probably wouldn't thrill any of the three companies
I mentioned, but I did promise to attempt some article on my experiences
with voice input and this is at least a lengthy beginning.  I'll add links
to the three companies I mentioned and I urge anyone interested to check
out all three (there may be others I've not seem that are worth
considering).  There are doubtless considerations I've not thought of and
advantages some have of which I'm unaware.  Also, Gerry Gold might comment
on his use of the version of VoiceType that comes with IBM OS/2, as might
Don Harber on the Windows version of that software.

Please email any questions you have about my use of Kurzweil VoicePad Pro,
or if you think others would really be interested, post to the list with a
cc to me to ensure I see it immediately.  And do tell me if there is more
about this that you'd like written here.

Take care all

Bruce Couper,  in Oshawa, Ontario, Canada

=====================================

Kurzweil
http://www.kurzweil.com/

IBM VoiceType Simply Speaking
http://www.software.ibm.com/is/voicetype/simply-speaking/usa/speaktxt.html

Dragon Systems
http://www.dragonsys.com/

From alt.support.mult-sclerosis Sat May 17 15:06:31 1997
From: 2 Bells <dbell@wolfenet.com>
Date: Sat, 10 May 1997 23:39:19 -0700
Newsgroups: alt.support.mult-sclerosis
Subject: Re: Methotrexate
Status: O
X-Status: 

I have been on Methotrexate since last fall. I take 10mg once a week
(upped from 7.5 in April). I have had absoulutly no side effects. Am
feeling stronger and more alert. If you had limited use of your hands
you may want to consider the fact that methotrexate has shown to be more
effectibe on CP MS and more effective on symptoms of upper extremities.
It is certainly worth a try. After all, you can quit if you feel it is
not worth taking.    Good Luck   Janet

From alt.support.mult-sclerosis Sat May 17 15:09:38 1997
From: Kathy G <Frostypoo@AOL.COM>
Date: Sun, 11 May 1997 08:34:26 -0400
Newsgroups: alt.support.mult-sclerosis
Subject: Re: 4-AP, Methotrexate
Status: O
X-Status: 

In a message dated 97-05-10 13:12:18 EDT, you write:

<< My husband was asked today while at the Mellen Center/Cleveland to
 consider using 4-AP.  We would like to get some feedback.  He has also
 been on methotrexate for 32 months and is considered to be doing well on
 it.  I would like to have information pertaining to side effects, and what
 pharmacies are being used, the price range for the drug as we are on
 Medicare with no payment for drugs.  Thanks >>


I have taken 4AP for over two years and found it to be a wonderful help.  I
have read that is especially effective for people who are temperature
sensitive.
Here is the information provided to me by the Shepherd Center Apothecary in
Atlanta, GA. (phone 404-350-7743) but I suggest that your neuro contact a
doctor at the Shepherd MS Center, to get more information on their success
with this drug.

4-Aminopyridine (4AP)

Description:
4-AP is a chemical that has shown the ability to restore nerve conduction in
demyelinated nerve fibers by prolongation of the repolarization phase of the
action potential.  It is classified as a potassium (K+) channel blocker.  It
has been prescribed for fatigue and heat sensitivity associated with multiple
sclerosis.

Availability:

4-AP is not available commercially in the United States.  It is not
manufactured by any drug company in the United States.  It is considered an
orphan drug by the FDA.  It is compounded by the Shepherd Center Apothecary
and dispensed only upon perscription.

Formulation:

4-AP is compounded in a slow release formulation of Methocel E4M.  This
formulation enables the drug to be released over an 8-12 hour period.

The most serious side effect has been seizures, but also include burning,
numbnedss,dizziness, light headedness, walking instability, nausea, vomiting,
restlessness and anxiety, abdominal pain, constipation, and headache.

Hope this helps.  I have had no side effects with this drug.

Kathy G.

From alt.support.mult-sclerosis Sat May 17 15:11:07 1997
From: Kathy G <Frostypoo@AOL.COM>
Date: Sun, 11 May 1997 08:56:08 -0400
Newsgroups: alt.support.mult-sclerosis
Subject: Re: 4-AP, Methotrexate
Status: O
X-Status: 

In a message dated 97-05-11 07:56:14 EDT, you write:

<< Cost should be the least of your worries re. 4-AP.  There are many folks
 on it who are in this group.  Listen carefully to what they say about
 where to get the drug and make sure they have been using the drug for
 some time before you use their pharmacy.  I understand there is one in
 Texas somewhere with a good reputation.

 The study on 4-AP has been halted until the researchers can find a way to
 make the drug stable.  It seems to increase strength with time and the MS
 clinics around the country have been reporting an increase of people on
 4-AP coming in to their emergency rooms with seizure activity.  These
 folks are getting the drug from different sources.  So, when you buy the
 drug, be sure the folks that recommend the source have used it for a
 while and buy only a month or two supply at a time.

 I have had correspondence with several from this group that have been on
 4-AP for more than a year and have had no problem and feel it benefits
 them.  Sorry, don't have names to give you.  If I recall right, they were
 also taking the drug in the lower or mid recommended range too.  Talk
 carefully with these folks.  Your post was a little vague on whether or
 not your doc has much experience with the drug.  Seems that he should
 have been able to give you a good, secure source if he had lots of
 experience.

                L >>

